Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Charissa Jessurun"'
Autor:
Noah L A Nawabi, Akiro H Duey, John L Kilgallon, Charissa Jessurun, Joanne Doucette, Rania A Mekary, Mohammad Ali Aziz-Sultan
Publikováno v:
Journal of NeuroInterventional Surgery. 14:642-649
ObjectivesCOVID-19 presents a risk for delays to stroke treatment. We examined how COVID-19 affected stroke response times.MethodsA literature search was conducted to identify articles covering stroke during COVID-19 that included time metrics data p
Autor:
Marike L. D. Broekman, Charissa Jessurun, Rania A. Mekary, Anouk E. de Wit, Ishaan Ashwini Tewarie, Alexander F. C. Hulsbergen, Joost J.C. Verhoeff, John G. Phillips, David A. Reardon, Tom J. Snijders
Publikováno v:
Neuro Oncol
Neuro-Oncology, 23(8), 1261-1272. OXFORD UNIV PRESS INC
Neuro-Oncology
Neuro-Oncology, 23(8), 1261-1272. OXFORD UNIV PRESS INC
Neuro-Oncology
BackgroundImmune checkpoint inhibitors (ICI) have been a breakthrough for selected cancer patients, including those with brain metastases (BMs). Likewise, steroids have been an integral component of symptomatic management of BM patients. However, cli
Autor:
Jasper Gerritsen, Rosa Zwarthoed, John Kilgallon, Noah Nawabi, Charissa Jessurun, Georges Versyck, Koen Pruijn, Fleur Fisher, Emma Larivière, Lien Solie, Rania Mekary, Djaina Satoer, Joost Schouten, Eelke Bos, Fred Kloet, Rishi Nandoe Tewarie, Timothy R. Smith, Clemens Dirven, Steven De Vleeschouwer, Marike Broekman, Arnaud Vincent
Publikováno v:
Neurosurgery. 69:50-50
Autor:
S. Nagtegaal, Alexander F. C. Hulsbergen, Marike L. D. Broekman, Charissa Jessurun, Timothy R. Smith, Joost J.C. Verhoeff, E. Van Dorst, Vasileios K. Kavouridis
Publikováno v:
Clinical and Translational Radiation Oncology, 24, 11-15. ELSEVIER IRELAND LTD
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 24, Iss, Pp 11-15 (2020)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 24, Iss, Pp 11-15 (2020)
Highlights • The largest cohort of brain metastases patients from gynaecological tumours. • CA-125, age and primary tumour type are prognostic for survival. • This will inform clinical practice and aid the development of new prognostic tools.
Autor:
Marike Broekman, Alexander F. C. Hulsbergen, Timothy R. Smith, Charissa Jessurun, Rania A. Mekary, Ishaan Ashwini Tewarie
Publikováno v:
Neuro-oncology Advances
Background Leptomeningeal disease (LMD) is a complication distinguished by progression of metastatic disease into the leptomeninges and subsequent spread via cerebrospinal fluid (CSF). Although treatments for LMD exist, it is considered fatal with a
Autor:
Charissa Jessurun, Alexander F.C Hulsbergen, Anouk de Wit, Rania Mekary, Ishaan Tewarie, Marike Broekman
Publikováno v:
Neurosurgery. 67
Autor:
Jasper Gerritsen, Rosa Zwarthoed, Georges Versyck, Charissa Jessurun, Koen Pruijn, Fleur Fisher, John Kilgallon, Noah Nawabi, Emma Larivière, Lien Solie, Sil de Jong, Djaina Satoer, Joost Schouten, Eelke Bos, Alfred Kloet, Rishi Nandoe Tewarie, Timothy R. Smith, Clemens M.F. Dirven, Steven De Vleeschouwer, Marike Broekman, Arnaud Vincent
Publikováno v:
Neurosurgery. 68:138-138
IMMU-03. IMMUNE CHECKPOINT INHIBITORS IN SMALL CELL LUNG CANCER PATIENTS DEVELOPING BRAIN METASTASES
Autor:
Ishaan Ashwini Tewarie, Alexander Hulsbergen, Timothy R. Smith, John G. Phillips, Marike L. D. Broekman, Charissa Jessurun
Publikováno v:
Neuro Oncol
INTRODUCTION Small cell lung cancer (SCLC) is known for rapid growth, and about 40-50% of SCLC patients will develop brain metastases (BM). The addition of immune checkpoint inhibitors (ICI) to the standard chemotherapy, which is the current backbone
Autor:
Alexander F. C. Hulsbergen, Marike L. D. Broekman, Charissa Jessurun, Rishi Nandoe Tewarie, Timothy R. Smith
Publikováno v:
Neuro Oncol
INTRODUCTION Steroids are commonly used for treatment of peritumoral edema and increased intracranial pressure in brain tumor patients. However, despite the widespread use of steroids, relatively little evidence is available about the optimal dosing
Autor:
Marike L. D. Broekman, Anouk E. de Wit, Charissa Jessurun, Alexander Hulsbergen, Ishaan Ramlochan Tewarie
Publikováno v:
Neuro-oncology Advances
INTRODUCTION Immune checkpoint inhibitors (ICI) are increasingly being administered to cancer patients, including those with brain metastases (BMs). However, little is known about the interaction between ICI and steroids such as dexamethasone. The ai